Publikationen in Zusammenarbeit mit Forschern von Universidad Autónoma de Madrid (10)

2022

  1. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

2019

  1. The Masked Polar Group Incorporation (MPGI) Strategy in Drug Design: Effects of Nitrogen Substitutions on Combretastatin and Isocombretastatin Tubulin Inhibitors

    Molecules (Basel, Switzerland), Vol. 24, Núm. 23

2017

  1. Deferasirox-induced iron depletion promotes BclxL downregulation and death of proximal tubular cells

    Scientific Reports, Vol. 7

  2. Differential effect of quercetin on cisplatin-induced toxicity in kidney and tumor tissues

    Food and Chemical Toxicology, Vol. 107, pp. 226-236

  3. Regulation of miR-29b and miR-30c by vitamin D receptor activators contributes to attenuate uraemia-induced cardiac fibrosis

    Nephrology Dialysis Transplantation, Vol. 32, Núm. 11, pp. 1831-1840

2014

  1. Impaired wound repair in adult endoglin heterozygous mice associated with lower NO bioavailability

    Journal of Investigative Dermatology, Vol. 134, Núm. 1, pp. 247-255

2013

  1. Endothelial endoglin is involved in inflammation: Role in leukocyte adhesion and transmigration

    Blood, Vol. 121, Núm. 2, pp. 403-415

2011

  1. net Etiopathology of chronic tubular, glomerular and renovascular nephropathies: Clinical implications

    Journal of Translational Medicine, Vol. 9

2007

  1. Gene expression fingerprinting for human hereditary hemorrhagic telangiectasia

    Human Molecular Genetics, Vol. 16, Núm. 13, pp. 1515-1533

2005

  1. Characterization of murine S-endoglin isoform and its effects on tumor development

    Oncogene, Vol. 24, Núm. 27, pp. 4450-4461